Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Q4 EARNINGS: Danaher in line, but Philips’ dismal run continues

This article was originally published in Clinica

Executive Summary

Danaher’s fourth-quarter sales of $5.42bn and adjusted earnings of $1.04 per share came in just ahead of analyst consensus of $5.39bn and $1.03 per share, respectively. Q4 sales were up 3% year-on-year, while core revenues increased 4%; this beat consensus analyst prediction of 2.8% growth and the best result since Q4 2011, according to Jefferies analyst Brandon Couillard. “The upside came from better T&M [test & measurement], environmental and industrial trends,” he added.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel